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Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most worldwide frequent primary
carcinomas resulting in the death of many cirrhotic patients. Unfortunately, the molecular
mechanisms of this cancer are not well understood; therefore, we need a good model system to
study HCC. The dog is recognized as a promising model for human medical research, namely
compared with rodents. The objective of this study was to establish and characterize a spontaneous
canine tumor cell line as a potential model for studies on HCC.
Results:  Histomorphological, biochemical, molecular biological and quantitative assays were
performed to characterize the canine HCC cell line that originated from a dog with a spontaneous
liver tumor. Morphological investigations provided strong evidence for the hepatocytic and
neoplastic nature of the cell line, while biochemical assays showed that they produced liver-specific
enzymes. PCR analysis confirmed expression of ceruloplasmin, alpha-fetoprotein and serum
albumin. Quantitative RT-PCR showed that the canine HCC cell line resembles human HCC based
on the measurements of expression profiles of genes involved in cell proliferation and apoptosis.
Conclusions: We have developed a novel, spontaneous tumor liver cell line of canine origin that
has many characteristics of human HCC. Therefore, the canine HCC cell line might be an excellent
model for comparative studies on the molecular pathogenesis of HCC.
Background
Hepatocellular carcinoma (HCC) is one of the most
worldwide frequent primary tumors in man, with an esti-
mated 564,000 new cases and almost as many deaths in
2000 [1]. It almost always develops in the setting of
chronic hepatitis or cirrhosis, conditions in which many
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hepatocytes are destroyed, inflammatory cells invade the
liver, and connective tissue is deposited. Unlike colorectal
carcinoma, for example, for which a model can be gener-
ated based on known molecular events occurring during
the process of carcinogenesis [2], the pathogenesis of
HCC is largely unknown [3]. Although many risk factors
have been reported to be involved in the transformation
from a normal cell into a malignant tumor cell, such as
HBV, HCV, alcohol, aflatoxin B, cirrhosis, older age, and
male gender, the molecular mechanisms of neoplastic
transformation and progression in HCC are not yet well
understood.
However, the study of those mechanisms is hampered
because the liver tissue of patients with HCC has only lim-
ited value and primary hepatocytes are difficult to main-
tain in culture. Furthermore, primary hepatocytes rapidly
lose detoxifying P450 isoenzymes. In addition, and
because of the heterogeneity of the molecular genetic
changes that can lead to HCC across species, molecular
genetic studies in animals have not yet provided a precise
general model for the molecular pathogenesis of HCC in
humans. The dog is a valuable model for human compar-
ative studies, since it has a comparative life span and hab-
itat and thus similar risk factors and its domestication
started over 10,000 years ago [4]. Moreover, and like
rodents, the dog develops spontaneous hepatocellular
tumors. However, these tumors are not associated with
hepatitis and cirrhosis, and develop in normal livers. Fur-
thermore, the entire genome of the dog is currently being
sequenced, what will allow further detailed species-spe-
cific molecular analyses.
Here, we describe the establishment and morphological,
immunohistochemical, biochemical, and molecular char-
acterization of the first canine hepatocyte cell line derived
from a spontaneous HCC of a dog. The objective of this
study was to investigate whether this cell line could be
used as a potential model for studies on human HCC.
Therefore, we investigated whether this canine hepatocyte
tumor cell line had features similar to human HCC with
respect to mutations in the hepatocyte growth factor
receptor (c-MET) gene and the differential gene expression
of several oncogenes, proto-oncogenes and proteins
involved in proliferation, apoptosis and cell survival.
Results
Histopathology of the donor dog
The primary neoplasm was histologically characterized by
broad trabeculae, 2 – 6 cells in thickness, of well-differen-
tiated hepatocytes and separated by sinusoidal structures
lined by endothelium. The hepatocytes had uniform
moderately sized nuclei and small nucleoli; mitotic fig-
ures were very rare. Regularly areas with marked steatosis
or glycogen accumulation within the neoplastic hepato-
cytes were observed. Locally within this well differentiated
tumor there was a carcinomatous area characterized by
broad trabeculae of more basophilic cells with large
nuclei, moderate anisokaryosis, usually one or more large
nucleoli and 3–5 mitotic figures per high power field (Fig-
ure 1). The non-affected liver histology of the donor dog
showed no abnormalities, such as inflammation.
Development and histomorphological characterization
Directly after establishment of the initial cell suspension
(June 19, 2002), the cells appeared pleiomorphic. After
approximately 10 weeks of culturing, the cells formed
clusters as rounded, vital cells, which are non-adherent.
This characteristic has remained ever since. Freezing and
Histopathological characteristics of the original liver tumor  from which the cHCC cell line is derived Figure 1
Histopathological characteristics of the original liver tumor 
from which the cHCC cell line is derived. A) A well-defined 
tumor area (*), as well as a carcinomatous area (**); B) An 
enlargement of the carcinomatous area (**).
*
* *
* *
A
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re-culturing of the cell line had no effect on cell growth. A
1:10 splitting and medium refreshment of the culture by
careful trypsinization once a week (a "passage") is opti-
mal. The tryspinized cell clusters were further cultured
with fresh DMEM culture medium. The cells rather grow
in these smaller clusters and not as single cells.
The cell clusters were collected, fixed and handled as
described. As shown in Figure 2, histology revealed solid
cell clusters of large epithelial cells, with papillary projec-
tions at the periphery and extensive central necrosis. The
cells were polygonal and moderately pleiomorphic, 10 –
20 µm in the largest diameter, showed marked anisocyto-
sis and sometimes vacuolation of the cytoplasm. The
nuclei were large (5–10 µm) and centrally located, with
large and often multiple prominent nucleoli, and many,
sometimes bizarre, mitotic figures (Figures 2A and 2B).
Immunohistochemical staining for both HepPar1 and
CK7 was best after Bouin fixation. In the Bouin fixed
material, the hepatocyte marker HepPar1 (Figure 3A)
revealed moderate granular cytoplasmic staining in the
majority of the cells; CK7 (Figure 3B) showed slight to
moderate granular cytoplasmic staining in a minority of
the cells. As controls for the two stainings, liver tissue and
kidney tissue of a healthy dog was used. These were posi-
tively and negatively stained, respectively. HepPar1 stain-
ing shows throughout the liver tissue samples, whereas
the CK7 is localized in the bile ducts.
Biochemical characterization
The activity of ALT, GLDH and AST was measured to
investigate whether the cHCC cells produced liver charac-
teristic enzymes. In order to compare the amount of
hepatic enzymes produced by the cHCC cell line, those
measurements were also performed for the widely used
human hepatocyte cell line HepG2 (enzyme activity of
HepG2 was set at 100%), and the commonly used canine
kidney cell line MDCK. The results showed the cHCC cell
line produced 25% of the highly liver-specific ALT com-
pared to HepG2, whereas the MDCKs did not produce
ALT at all (Table 3). Of another specific liver enzyme,
GLDH, the cHCC cell line produced 19% of the activity of
HepG2, whereas the MDCK cells produced only 10%. The
cHCC cell line produced 28% of AST compared to HepG2,
whereas MDCK produced only 8%.
Molecular characterization
To further examine whether the cell line truly consists of
hepatocytes, we isolated RNA from the cHCC, made
cDNA, and performed PCRs for the gene expression of
hepatocyte markers. The cHCCs proved to be PCR-posi-
tive for canine serum albumin, alpha-fetoprotein and cer-
uloplasmin. All obtained products were sequence
confirmed.
Mutations in the c-MET gene
Mutations in exons 15–21 of the c-MET gene have been
described in human HCC. A PCR was therefore performed
with primers based on this region of the c-MET gene. The
products were analyzed and aligned with known canine
and human c-MET sequences (Gen Bank Accession num-
bers AB118945 and NM_000245, respectively). At nucle-
otide position 4089, a thymine (T) instead of an adenine
(A) was observed, which resulted in a serine in the cHCC
cell line versus a threonine in healthy tissue at codon 1363
(T1363S) (see Figure 4).
Histomorphological characterization cHCC cell line Figure 2
Histomorphological characterization cHCC cell line. A) Solid 
cell clusters of large epithelial cells with papillary projections 
at the periphery and extensive central necrosis. Bouin fixa-
tion, HE staining; B) Papillary growth of moderately pleio-
morphic cells with anisocytosis and anisokaryosis, prominent 
nucleoli, and multiple mitotic figures. Carnoy fixation, HE 
staining.
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Quantitative measurements of mRNA levels of gene 
products differentially expressed in cHCC
To explore whether the cHCC cell line has similar expres-
sion profiles of genes involved in neoplastic growth and
apoptosis as human HCC, the mRNA levels of the follow-
ing genes were measured by means of quantitative RT-
PCR: c-MET, PTEN, p27kip, Bcl-2, beta-catenin, SOCS3,
ODC, TGF-alpha and collagen-1. The expressions of these
genes were normalized by relating them to the housekeep-
ing genes, HPRT and beta-actin. As shown in Figure 5, c-
MET, a receptor tyrosine kinase involved in cell survival
and growth, was down-regulated 33-fold compared to the
control group. PTEN, an inactivator of the Akt/PKB path-
way was down-regulated over 200-fold. To further sub-
stantiate activation of Akt/PKB, we measured two
downstream targets, p27kip and Bcl-2. They were indeed
down-regulated 5-fold and up-regulated 3-fold, respec-
tively. HGF, the ligand of c-MET, induces mRNA levels of
beta-catenin and TGF-alpha, both involved in cellular
growth. The latter two were down-regulated 6- and 7-fold,
respectively. From two novel proteins associated with
hepatocellular carcinomas in man [5], suppressors of
cytokine signaling type 3 (SOCS3) and collagen-I, a non-
significant 2-fold elevation of SOCS3, were found and a 7-
fold, significant down-regulation of collagen-I was
observed. The gene expression of a proliferation factor,
ornithine decarboxcylase (ODC), also proved to be ele-
vated 3-fold.
Discussion
We have described the establishment and characterization
of a canine hepatocyte tumor cell line, derived from a
spontaneous HCC in a dog. Both immortalized hepato-
cytes and hepatic progenitor cells come from various
transgenic mouse lines [6], are drug-induced [7], or are
obtained after SV40 large T-antigen transfection [8]. How-
ever, immortalization with SV40 induces HGF/c-MET acti-
vation via an autocrine HGF loop [9]. This clearly
contrasts with the cHCC, where HGF-induced growth is
absent (data not shown), most likely because of severely
reduced c-MET levels.
Our morphological study has accumulated good evidence
– but no definitive proof of the hepatocytic and neoplastic
nature of the cHCC cells. Positive staining for hepatocyte
marker HepPar1 strongly indicates the hepatocytic origin
of the cultured cells [10]. The neoplastic nature of the cells
can be deduced from the pleiomorphism of the cells, the
number of sometimes bizarre mitotic figures. The simul-
taneous presence of CK7 and HepPar1 positive cells is also
consistent with the neoplastic nature of the cells [11], and
suggests the presence of both fully differentiated hepato-
cytes and progenitor cells in the cHCC cell culture. The
hepatocytic nature of the cHCC cell line is further
indicated by the activity of the liver-specific enzyme ALT
Immunohistochemical characterization cHCC cell line Figure 3
Immunohistochemical characterization cHCC cell line. A) 
Immunohistochemical staining for HepPar1. Moderate granu-
lar cytoplasmic staining in the majority of the cells. Bouin fix-
ation; B) Immunohistochemical staining for CK7. Slight to 
moderate granular cytoplasmic staining in a minority of the 
cells. Bouin fixation.
Table 3: Liver enzyme activity measurement of the cHCC cell 
line compared with HepG2 and MDCK.*
ALT (%) AST (%) GLDH (%)
HepG2 100 100 100
cHCC 25.8 27.7 19
MDCK 08 1 0
* Note: The activity of the enzymes is given as a percentage compared 
to the activity of proteins in HepG2.
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and the expression of hepatocyte markers, like serum
albumin, ceruloplasmin, and alpha-fetoprotein, as it is
also the case for the human tumor liver cell line HepG2.
Binding of HGF to c-MET triggers tyrosine autophosphor-
ylation of the intracellular domain in the c-MET receptor
and induces responses that account for mitogenesis and
growth. In human c-MET, point mutations have been
described in the tyrosine kinase domain, which may be
associated with the development of primary liver carcino-
mas [12]. In our study, we detected an unknown point
mutation near the tyrosine kinase domain, which results
in a conserved change from a threonine to a serine.
Whether this mutation has any influence on the
autophosphorylation of two adjacent tyrosines [13]
remains to be proven.
In quantitative RT-PCRs, we measured the differential
gene expressions of several gene products involved in pro-
liferation/growth and cell survival. In human HCC, the c-
MET gene-expression was observed to be induced in 60%
of the cases [14], whereas we found a down-regulation of
the c-MET gene-expression. Although we only measured
mRNA levels of c-MET, we can correlate them to their pro-
tein expression levels [15]. Furthermore, lack of HGF-
responsiveness was also observed by reduced expression
of beta-catenin and TGF-alpha in the cHCC cell line,
which is in accordance with findings in human HCC [16].
It has also been observed that the tumor-suppressor
PTEN, the Akt/PKB pathway inhibitor [17], was down-reg-
ulated drastically, leading to an increased activity of Akt/
PKB, as shown by the anti-apoptotic protein Bcl-2 and the
cell-cycle inhibitor p27kip, which were induced and
inhibited, respectively. Both p27kip and PTEN are inhib-
ited in human HCC as well [17,18]. In addition, the gene
expressions in cHCC of SOCS3 and collagen-I were ele-
vated (although not significantly) and inhibited, respec-
tively, as it was also detected in human HCC [19].
Moreover, we found an up-regulation for ODC. This pro-
liferation factor, induced by several growth factors, is
responsible for proliferation in many cell types [20].
Taken together, the expression data show elevated
proliferation, increased cell survival, and reduced apopto-
sis, which explains the neoplastic nature of cHCC.
Conclusions
From the morphological, biochemical, and molecular
biological assays performed in this study, we conclude
that the cHCC cell line clearly represents hepatocytes. In
Mutation in the c-MET gene of cHCC (in figure as "c-MET cHCC") compared to healthy liver tissue (canine c-MET; Gen Bank  accession number AB118945; "canine c-MET" in figure) and human c-MET (Gen Bank accession number NM_000245; "c-MET  human" in figure) sequences Figure 4
Mutation in the c-MET gene of cHCC (in figure as "c-MET cHCC") compared to healthy liver tissue (canine c-MET; Gen Bank 
accession number AB118945; "canine c-MET" in figure) and human c-MET (Gen Bank accession number NM_000245; "c-MET 
human" in figure) sequences. nt 4021–4219 of the canine c-MET is shown. The mutation is marked in grey at nt 4089 (A to T) 
of the canine c-MET, which corresponds to a change of amino acid 1363, from a threonine to a serine (T1363S). The STOP 
codon in the canine and human c-MET is also marked in grey. Alignment was performed by SECentral CLUSTAL W (1.7) mul-
tiple sequence alignment.
c-MET cHCC.seq GGCACCCTAGAGCTGAACTGCGCCCATCTTTTTCTGAACTGGTCTCCAGGATATCAGCAA
canine c-MET.seq GGCACCCTAGAGCTGAACTGCGCCCATCTTTTTCTGAACTGGTCTCCAGGATATCAGCAA
c-MET human.seq GGCACCCTAAAGCCGAAATGCGCCCATCCTTTTCTGAACTGGTGTCCCGGATATCAGCGA
********* *** *** ********** ************** *** ********** *
c-MET cHCC.seq TATTCTCTTCTTTCATTGGGGAGCACTATGTCCATGTGAACGCCACTTATGTGAATGTC
canine c-MET.seq TATTCTCTACTTTCATTGGGGAGCACTATGTCCATGTGAACGCCACTTATGTGAATGTC
c-MET human.seq TCTTCTCTACTTTCATTGGGGAGCACTATGTCCATGTGAACGCTACTTATGTGAACGTA
* ****** ********************************** ******** *** ** 
c-MET cHCC.seq AAATGTGTTGCTCCATACCCTT--------------------------------------
canine c-MET.seq AAATGTGTTGCTCCATACCCTTCTCTCTTGTCATCACAAGATAACATTGATGGCGAGGGG
c-MET human.seq AAATGTGTCGCTCCGTATCCTTCTCTGTTGTCATCAGAAGATAACGCTGATGATGAGGTG
******** ***** ** **** STOPComparative Hepatology 2004, 3:9 http://www.comparative-hepatology.com/content/3/1/9
Page 6 of 10
(page number not for citation purposes)
addition, cHCC has neoplastic characteristics comparable
to HCC in man. Therefore, this cell line can be used as a
model not only to study the molecular pathogenesis of
human HCC, but also to investigate possible etiological
agents of canine hepatitis.
Methods
Donor dog
Our material was taken from the liver of an eleven-year
old, privately owned female Cairn Terrier dog, diagnosed
with HCC by histological analysis. With the owners'
consent, the dog was routinely anesthetized, parts were
taken from various areas of the neoplastic liver tissue. In
addition, liver tissue was collected for histological analy-
sis, fixed in 10% buffered formalin and paraffin embed-
ded. Sections were routinely stained with hematoxylin
and eosin (HE). Then, the dog was immediately
euthanized.
Isolation and culturing conditions
Immediately after resection, the liver samples were kept in
DMEM culture medium supplemented with 10% fetal calf
serum (FCS; Fetal Calf Serum Gold, PAA Laboratories
GmBH, Pasching, Austria), penicillin and streptomycin
(P/S; 100 IU/ml and 100 µg/ml final concentration,
respectively) and were kept on ice. Under sterile condi-
tions, liver samples of various areas were cut into small
pieces (5 × 5 mm) and trypsinized with 30 ml of trypsin/
EDTA (0.5 g/l trypsin 1:250 and 0.2 g/l EDTA; BioWhit-
taker Europe, Verviers, Belgium) in a sterile Erlenmeyer
flask placed on a stirring platform for 30 minutes. The cell
suspensions were filtered with a 70 µm nylon filter (Fal-
con; Becton Dickinson Labware, Franklin Lakes, NJ).
Erythrocytes were lysed from the filtered suspension. The
remaining cell suspension was resuspended in DMEM
supplemented with 10% FCS and P/S and was cultured at
37°C with 5% CO2 and 95% air under a humidified
atmosphere in non-coated flasks. It was observed every
day for any changes. The medium was refreshed twice a
week.
Histomorphological characterization
After 3 weeks of culturing with medium refreshment only
and no splitting of the culture, the content of a T80 cm2
flask with the cHCC cell culture was harvested by transfer-
ring the entire contents of the flask to a tube, which was
Differential gene expression profiles of the cHCC cell line as compared to liver tissue of healthy dogs, measured by quantitative  Real-Time PCR Figure 5
Differential gene expression profiles of the cHCC cell line as compared to liver tissue of healthy dogs, measured by quantitative 
Real-Time PCR. Data represent mean ± SE of the groups. The "n" for these figures stands for the fold change of the gene 
expressions of the cell line as compared with our control group.
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centrifuged for 10 minutes at 1,500 g. The supernatant
was replaced by freshly made fixation fluid for 4 hours.
For optimal immunohistochemical staining, four differ-
ent fixatives were used: zinc sulfate formalin, Bouin, Car-
noy, and 10% neutral buffered formalin. The fixated cell
pellet was transferred to a foam leaf-protected plastic
embedding cassette. After fixation, samples were manu-
ally dehydrated and embedded in paraffin. Sections (3 µm
thick) were cut and stained with hematoxylin and eosin
(HE). For immunohistochemical staining, paraffin sec-
tions were mounted on poly-L-lysine coated slides, post-
fixed into ice-cold acetone fixation fluid for 10 minutes,
air dried and stored at room temperature (RT) until use.
For the detection of HepPar1, slides were deparaffinized,
immersed in 10 mM Tris, 1 mM EDTA buffer (pH 9),
heated in a microwave oven for 10 minutes for antigen
retrieval, cooled down for 10 minutes at RT and washed
in PBS buffer. Endogenous peroxidase activity was
blocked by 0.3% H2O2, in methanol, for 30 minutes at
RT. After washing with PBS buffer containing 0.1%Tween-
20, background staining was blocked by incubating the
sections with normal goat serum (1:10 diluted in PBS), for
30 minutes. Sections were incubated overnight at 4°C
with the primary antibody HepPar1 (clone OCH1E5,
Dakocytomation, Glostrup, Denmark) diluted 1:50 in
PBS. After washing in PBS-Tween, slides were incubated in
DAKO EnVision™ + reagent, HRP-labeled (Dakocytoma-
tion,) for 45 minutes at RT. After washing in PBS buffer,
sections were developed using 3,3-diaminobenzidine as
chromogen, and counterstained with hematoxylin.
For the detection of CK7, the slides were treated as
described above but without antigen retrieval, and
incubated overnight at 4°C with mouse anti-human CK7,
clone OV-TL 12/30 (Dakocytomation), diluted 1:25 in
PBS with 1% bovine serum albumin. For both HepPar1
and CK7, formalin-fixed paraffin-embedded canine liver
and kidney tissue controls were incubated with and with-
out the primary antibody. In contrast to the cell culture, in
the liver tissue antigen retrieval for CK7 was necessary
and, therefore, a 40-minute proteinase-K (Dakocytoma-
tion) digestion at RT was performed before blocking of
the endogenous peroxidase, in methanol.
Biochemical characterization
The content of a T80 cm2 flask with the cHCC cell culture
was harvested, spun down for 5 minutes at 1,500 g, the
cell pellet was washed in 10 ml PBS, centrifuged for 5 min-
utes at 1,500 g and the cells were resuspended in 1 ml PBS.
Two hundred µl of the cell suspension were lysed and
homogenized with a pestle in RIPA buffer containing 1%
Igepal, 0.6 mM phenylmethylsulfonyl fluoride, 17 µg/ml
aprotinine and 1 mM sodium orthovanadate (Sigma
Chemical Co., Zwijndrecht, The Netherlands), for 30
minutes on ice. Total protein concentrations were calcu-
lated using a Lowry-based assay (DC Protein Assay, Bio-
Rad, Veenendaal, The Netherlands).
For the liver enzyme measurement, 800 µl of the cell sus-
pension was centrifuged at 12,100 g for 5 minutes. The
pellet was lysed in milliQ by vortexing, centrifuged again
for 5 minutes at 12,100 g and the supernatant was ana-
lyzed in a Beckman Synchron CX7 analyzer. The follow-
ing enzymes were measured: ALT, AST and GLDH. AST
and ALT were measured at 37°C with the Tris-pyridoxal
phosphate method with Beckman-Coulter reagent. GLDH
was measured with Roche reagent. All samples were sub-
jected to the external quality control mission of the Dutch
Foundation for Quality Assessment in Medical
Laboratories.
As comparison, the widely used human hepatoma cell
line HepG2 (Deutsche Sammlung von Mikroorganismen
und Zellkulturen GmbH, DSMZ, Germany) and MDCK
canine kidney cell line (own collection) were used. These
were grown to 80–100% confluency (T80 cm2  flask)
under standard culturing conditions, as described for the
cHCC cell line.
RNA isolation and reverse-transcription PCR
Total cellular RNA was isolated from each frozen canine
liver tissue in duplicate and from all the cell cultures used
in this study using the Qiagen RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer's
instructions. The RNA samples were treated with DNase-I
(Qiagen RNase-free DNase kit). In total 3 µg of RNA was
incubated with poly (dT) primers at 42°C for 45 min, in
a 60 µl reaction, using the reverse transcription system
(Promega Benelux, Leiden, The Netherlands).
Molecular characterization
To examine whether the cell line consisted of hepatocytes,
we isolated total RNA and made cDNA as described
above. PCRs were performed to investigate the gene
expressions of hepatocyte (albumin, alfa-fetoprotein, cer-
uloplasmin) markers. All reactions were performed in a
50 µl volume with a thermal cycler (MJ Research Inc.,
Watertown, MA). Reaction mixtures contained 0.2 µM of
each oligonucleotide primer (Isogen Life Science, Maars-
sen, The Netherlands), PCR buffer (Invitrogen Corpora-
tion, Carlsbad, CA), 2.5 U of Platinum Taq polymerase
(Invitrogen), 2 mM MgCl2 (Invitrogen) and 250 µM of
each nucleotide (Promega Corporation, Madison, WI).
The PCR conditions were: initial denaturation at 95°C for
4 min, followed by 40 cycles consisting of denaturation at
95°C for 1 minute, annealing at 60°C for 1 minute, elon-
gation at 72°C for 1 min, and, finally, an elongation step
at 72°C for 10 min. The PCR products were analyzed onComparative Hepatology 2004, 3:9 http://www.comparative-hepatology.com/content/3/1/9
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a 1.5% agarose gel, and the DNA fragments were
visualized with ethidium bromide. The primers used for
these PCRs are depicted in Table 1.
Mutations in c-MET
To investigate mutations in the tyrosine kinase domain of
c-MET, a PCR was performed with two overlapping primer
sets for this domain (Table 1), both resulting in an
approximately 750 bp product. PCR conditions were as
described above with an annealing temperature of 50°C.
The products were sequenced using an ABI 3100 Genetic
Analyzer (Applied Biosystems, Nieuwerkerk a/d IJssel,
The Netherlands). Sequence analysis and alignments were
performed with Lasergene software (DNASTAR Inc., Mad-
ison, WI).
Samples for Real Time PCR
Quantitative gene expression measurements of the cHCC
cell line were compared with a group of four healthy liver
tissues. Liver biopsies from the healthy dogs, which
included two Cairn terriers (breed of the donor dog), were
obtained under local anesthesia with a 16G biopsy needle
and immediately snap-frozen and stored at -70°C until
further analysis.
Table 1: Oligonucleotides for RT-PCR used in this study.
Primer Target Primer sequence (5'-3')
mutMETF1 C-terminal part of canine cMET CCT TGG AAA AGT AAT AGT TC
mutMETR1 C-terminal part of canine cMET GTT TCA TGT ATG GTA GGA C
mutMETF2 C-terminal part of canine cMET GAA GTT TCC CAG TTT CTG AGC
mutMETR2 C-terminal part of canine cMET AAG GGT ATG GAG CAA CAC AT
CSA U Serum albumin GTT CCT GGG CAC GTT TTT GTA TGA
CSA L Serum albumin CTT GGG GTG CTT TCT TGG TGT AAC
Ceruloplasmin U Ceruloplasmin GGA ATA TGA GGG GGC CAT CTA TC
Ceruloplasmin L Ceruloplasmin GCA CGT CCA CTT CAT TAC CCA TGC C
alpha-fetoprot U alpha-fetoprotein GGC TGC TCC GCC ATC CAT CC
alpha-fetoprot L alpha-fetoprotein TTT TCC CCA TCC TGC AGA CAC TCC
Table 2: Oligonucleotides for quantitative RT-PCR used in this study.
Primer Extension Primer sequence (5'-3') Tm Product size (bp) Accession Number
HPRT U AGCTTGCTGGTGAAAAGGAC 56 100 L77488/ L77489
L TTATAGTCAAGGGCATATCC
Beta-actin U GATATCGCCGCGCTCGTCGTC 55 350 Z70044
L GGCTGGGGTGTTGAAGGTCTC
c-MET U TGTGCTGTGAAATCCCTGAATAGAATC 58 112 AB118945
L CCAAGAGTGAGAGTACGTTTGGATGAC
PTEN U AGATGTTAGTGACAATGAACCT 64,5 110 U92435
L GTGATTTGTGTGTGCTGATC
P27Kip U CGGAGGGACGCCAAACAGG 59 90 AY455798
L GTCCCGGGTCAACTCTTCGTG
Bcl-2 U TGGAGAGCGTCAACCGGGAGATGT 62 87 AB116145
L AGGTGTGCAGATGCCGGTTCAGGT
Beta-catenin U ATGGGTAGGGCAAATCAGTAAGAGGT 64 107 AY485996
L AAGCATCGTATCACAGCAGGTTAC
TGF-alpha U CCGCCTTGGTGGTGGTCTCC 63 122 AY458143
L AGGGCGCTGGGCTTCTCGT
SOCS3 U ACACCAGCCTGCGCCTCAAGACCT 63 119 AY485997
L CGCCTCGCCGCCCGTCA
Collagen I U GTGTGTACAGAACGGCCTCA 61 111 AF056303
L TCGCAAATCACGTCATCG
ODC U GTGGGCGATTGGATGCTCTTTG 59 111 BI395954
L TGTTGGCCCCGACATCACATAGTAGComparative Hepatology 2004, 3:9 http://www.comparative-hepatology.com/content/3/1/9
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Quantitative measurements of mRNA levels of gene 
products involved in neoplastic growth and apoptosis
Real-Time PCR based on the high affinity double-
stranded DNA-binding dye SYBR green I (SYBR® green I,
BMA, Rockland, ME) was performed in triplicate in a
spectrofluorometric thermal cycler (iCycler®, BioRad). Per
reaction, 1.67 µl of cDNA was used in a 50 µl volume con-
taining 1 × manufacturer's buffer, 2 mM MgCl2, 0.5 ×
SYBR® green I, 200 µM dNTP's, 0.4 µM of each oligonucle-
otide primer, 1.25 units of AmpliTaq Gold (Applied Bio-
systems), on 96-well iCycler iQ plates (BioRad). Primers
(Table ) were designed using PrimerSelect software
(DNASTAR Inc.). All PCR protocols included 40 cycles
consisting of denaturation at 95°C for 20 sec, annealing
for 30 sec, and elongation at 72°C for 30 sec. Melt curves
(iCycler, BioRad), gel electrophoresis, and sequencing
were used to examine each sample for purity and specifi-
city. For each experimental sample, the amount of the
genes under study, and of the housekeeping genes HPRT
and beta-actin, were determined from the appropriate
standard curve in autonomous experiments. Results were
normalized according to the average amount of
housekeeping genes and the values divided by the nor-
malized values of the healthy group to generate relative
expression levels [5]. Statistical analysis was performed
using the Student T-test, and the level of significance was
set to a p value 0.05.
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forming growth factor alpha.
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